Swiss stocks recently showcased a robust performance, buoyed by positive earnings updates and the anticipation of further monetary easing by the Swiss National Bank. The benchmark SMI's upward movement reflects a resilient market environment that could be conducive for exploring investment opportunities, particularly in dividend-paying stocks which might offer investors both stability and potential income in such optimistic market conditions.
Article - MEININGER Hotel Wien Downtown Franz Extends Contract by 20 Years - MEININGER Hotel Wien Downtown Franz is to be renovated in 2024 following the prolongation of the contract until 2043.
21st Austria weekly - Marinomed Austrian Post 18/12/2023 [pic1]Marinomed: Marinomed Biotech AG considers strategic options for its Carragelose business and has mandated an external advisor. A structured process was initiated in which the advisor will start engaging with potential partners. This initiative meets attractive market environment those assets that comply new EU medical device regulation MDR. In May 2024 important interim period ends imposing challenging requirements all devices. Products don’t fulfil these lose their certificate must not be marketed. products necessary prerequisites MDR are backed by extensive clinical data comprising >1000 patients 12 international trials. is a unique patent-protected broadly active virus-blocking compound currently used marketed product portfolio prophylaxis treatment of viral respiratory infections. Recent data also support extension using Allergy Eye